XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities:    
Net loss $ (167,269) $ (80,645)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 53,614 57,629
Amortization of deferred drydocking and survey costs 32,414 16,076
Amortization of debt premium and discounts 2,418 (1,562)
Provision for deferred income taxes 107 759
Gain on asset dispositions, net 7,511 1,047
Affiliate credit loss impairment expense 53,581 0
Affiliate guarantee obligation 2,000 0
Long-lived asset impairments 67,634 5,224
Changes in investments in unconsolidated companies 0 435
Compensation expense - stock-based 3,959 16,599
Changes in assets and liabilities, net:    
Trade and other receivables 9,434 (11,796)
Changes in due to/from affiliate, net 9,852 14,898
Accounts payable (14,548) (8,267)
Accrued costs and expenses (18,189) (10,574)
Cash paid for deferred drydocking and survey costs (29,499) (43,701)
Other, net 3,809 9,268
Net cash provided by (used in) operating activities 1,806 (36,704)
Cash flows from investing activities:    
Proceeds from sales of assets 31,498 25,092
Additions to properties and equipment (4,682) (13,931)
Net cash provided by investing activities 26,816 11,161
Cash flows from financing activities:    
Principal payments on long-term debt (33,520) (6,458)
Taxes on share-based awards (702) (3,112)
Other 0 1
Net cash used in financing activities (34,222) (9,569)
Net change in cash, cash equivalents and restricted cash (5,600) (35,112)
Cash, cash equivalents and restricted cash at beginning of period 227,608 397,744
Cash, cash equivalents and restricted cash at end of period [1] 222,008 362,632
Supplemental disclosure of cash flow information:    
Interest, net of amounts capitalized 16,169 24,482
Income taxes $ 9,940 $ 10,386
[1] Cash, cash equivalents and restricted cash at September 30, 2020 includes $3.4 million in long-term restricted cash.